You are here

Low-Profile Wearable Drug Delivery System for Medical Countermeasures

Award Information
Agency: Department of Defense
Branch: Army
Contract: W911QY-19-P-0087
Agency Tracking Number: A183-143-0163
Amount: $99,972.63
Phase: Phase I
Program: SBIR
Solicitation Topic Code: A18-143
Solicitation Number: 18.3
Solicitation Year: 2018
Award Year: 2019
Award Start Date (Proposal Award Date): 2019-02-06
Award End Date (Contract End Date): 2019-11-30
Small Business Information
737 Concord Ave
Cambridge, MA 02138
United States
DUNS: 080316838
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Piercen Oliver
 Director of Research and Development
 (617) 621-8500
Business Contact
 Peter Howe
Phone: (617) 621-8500
Research Institution

All US Armed Forces personnel are trained on using auto-injectors (AIs) such as the ATNAA (Antidote Treatment – Nerve Agent Auto-Injector) and CANA (Convulsant Antidote for Nerve Agent) for use against nerve agent poisoning. Although effective, these AIs have many shortcomings, including risk of nerve and bone damage, accidental injection, and are not designed to provide rapid sequential doses or a programmed long-term dose. There is a strong unmet need for an on-body automated delivery device coupled to on-body sensors with remote activation that is capable of dosing-on-demand of multiple MCs for both traditional and novel threats. Clear Scientific proposes to develop a wearable drug-delivery system to meet the requirements of the modern warfighter. The prototype wearable will be capable of on-demand delivery of antidotes. The system will be small enough that several units could be placed on the body simultaneously. On board electronics will enable integration with on-body sensors and wireless systems.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government